← Back to searchRecruitingRecruiting
Evaluation of Resection Techniques for Pancreatic Tumors
NCT05128890 · Methodist Health System
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
About this study
The plan is to conduct a retrospective chart review of patients who have undergone pancreatic and liver resection by using Meditech and Epic. A non-identified database will be created after retrospectively reviewing each patient case involving pancreatic or liver resection at MDMC. The study period will start in January 2006 until December 2020. Variables will include demographics, clinical disease diagnoses, and operative parameters as well as indirect charges from the hospitalizations.
Eligibility criteria
Inclusion Criteria:
* Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC)
* Patients 18 years old or older
Exclusion Criteria:
* Patients that have not undergone pancreatic resection surgeries
* Patients under 18 years of age
Study design
Enrollment target: 431 participants
Age groups: adult, older_adult
Timeline
Starts: 2016-04-16
Estimated completion: 2027-04-26
Last updated: 2026-03-20
Interventions
Procedure: Resection techniques for pancreatic and liver tumors
Primary outcomes
- • Patient Survival (through study completion, an average of 1 year)
- • Length of stay (Up to 1 year)
- • Complication rates (through study completion, an average of 1 year)
Sponsor
Methodist Health System · other
Contacts & investigators
ContactColette N Ndjom, MS · contact · ClinicalResearch@mhd.com · 214-947-4681
ContactJennifer Kirchner · contact · jenniferkirchner@mhd.com · 214-947-4459
InvestigatorAlejandro Mejia, M.D. · principal_investigator, The Liver Institute, Methodist Dallas Medical Center
All locations (1)
Methodist Dallas Medical CenterRecruiting
Dallas, Texas, United States